Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies
Shirin Ahmadi, Manuela Berto Pucca, Jonas A. Jürgensen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Phage display and other peptide display technologies
Weronika Jaroszewicz, Joanna Morcinek-Orłowska, Karolina Pierzynowska, et al.
FEMS Microbiology Reviews (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 190
Advances in antibody phage display technology
Line Ledsgaard, Anne Ljungars, Charlotte Rimbault, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2151-2169
Open Access | Times Cited: 101
Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes
Line Ledsgaard, Jack Wade, Timothy P. Jenkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model
Melisa Bénard-Valle, Yessica Wouters, Anne Ljungars, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper
Christoffer V. Sørensen, Julián Fernández, Anna Christina Adams, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Clinical management of snakebite envenoming: Future perspectives
Muhammad Hamza, Cecilie Knudsen, Christeine Ariaranee Gnanathasan, et al.
Toxicon X (2021) Vol. 11, pp. 100079-100079
Open Access | Times Cited: 48
Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins
Esperanza Rivera‐de‐Torre, Charlotte Rimbault, Timothy P. Jenkins, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 36
Discovery of broadly‐neutralizing antibodies against brown recluse spider and Gadim scorpion sphingomyelinases using consensus toxins as antigens
Esperanza Rivera‐de‐Torre, Stefanos Lampadariou, Mark Møiniche, et al.
Protein Science (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 7
In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles
José Marı́a Gutiérrez, Mariángela Vargas, Álvaro Segura, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 34
Recent advancements in snake antivenom production
Anurag S. Rathore, Ramesh Kumar, Om Shanker Tiwari
International Journal of Biological Macromolecules (2023) Vol. 240, pp. 124478-124478
Closed Access | Times Cited: 14
Protecting the piglet gut microbiota against ETEC-mediated post-weaning diarrhoea using specific binding proteins
Timothy P. Jenkins, Norbert Ács, Emma Wenzel Arendrup, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Terrestrial venomous animals, the envenomings they cause, and treatment perspectives in the Middle East and North Africa
Timothy P. Jenkins, Shirin Ahmadi, Mátyás A. Bittenbinder, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 12, pp. e0009880-e0009880
Open Access | Times Cited: 29
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies
Suthimon Thumtecho, Nick J. Burlet, Anne Ljungars, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2023) Vol. 29
Open Access | Times Cited: 13
Orally active bivalent VHH construct prevents proliferation of F4+ enterotoxigenic Escherichia coli in weaned piglets
Berthe Katrine Fiil, Sandra Wingaard Thrane, Michael Jakob Pichler, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104003-104003
Open Access | Times Cited: 17
Practical progress towards the development of recombinant antivenoms for snakebite envenoming
Stefanie K. Menzies, Rohit N. Patel, Stuart Ainsworth
Expert Opinion on Drug Discovery (2025), pp. 1-21
Open Access
A single-chain variable fragment selected against a conformational epitope of a recombinantly produced snake toxin using phage display
Charlotte Rimbault, Pelle D. Knudsen, Anna Damsbo, et al.
New Biotechnology (2023) Vol. 76, pp. 23-32
Open Access | Times Cited: 8
The Need for Next-Generation Antivenom for Snakebite Envenomation in India
Muralidharan Vanuopadath, Karthika Rajan, Aswathy Alangode, et al.
Toxins (2023) Vol. 15, Iss. 8, pp. 510-510
Open Access | Times Cited: 8
Engineering of single-domain antibodies for next-generation snakebite antivenoms
Carla Freire Celedônio Fernandes, Soraya dos Santos Pereira, Marcos Barros Luiz, et al.
International Journal of Biological Macromolecules (2021) Vol. 185, pp. 240-250
Closed Access | Times Cited: 19
Cross-reactivity trends when selecting scFv antibodies against snake toxins using a phage display-based cross-panning strategy
Christoffer V. Sørensen, Line Ledsgaard, Helen H. K. Wildenauer, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera
Christoffer V. Sørensen, José R. Almeida, Markus‐Frederik Bohn, et al.
Toxicon (2023) Vol. 234, pp. 107307-107307
Open Access | Times Cited: 7
Analysis of the Necrosis-Inducing Components of the Venom of Naja atra and Assessment of the Neutralization Ability of Freeze-Dried Antivenom
Cheng-Hsuan Ho, Liao-Chun Chiang, Yan–Chiao Mao, et al.
Toxins (2021) Vol. 13, Iss. 9, pp. 619-619
Open Access | Times Cited: 17
Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile
Everardo Remi Rodríguez-Rodríguez, Rune Thorbjørn Nordvang, Marcus Petersson, et al.
Protein Science (2024) Vol. 33, Iss. 7
Open Access | Times Cited: 2
Crotalus Durissus Ruruima: Current Knowledge on Natural History, Medical Importance, and Clinical Toxinology
Manuela Berto Pucca, Paulo Sérgio Bernarde, Anderson Maciel Rocha, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Unraveling the structure and function of CdcPDE: A novel phosphodiesterase from Crotalus durissus collilineatus snake venom
Isadora Sousa de Oliveira, Manuela Berto Pucca, Gisele Adriano Wiezel, et al.
International Journal of Biological Macromolecules (2021) Vol. 178, pp. 180-192
Open Access | Times Cited: 13
The potential risks of equine serum therapy in transmitting new infectious diseases: lessons from a post-pandemic era
Manuela Berto Pucca, Ana Lucía Camphora
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top